Results 31 to 40 of about 9,301 (237)

Postoperative pain management in children: Guidance from the pain committee of the European Society for Paediatric Anaesthesiology (ESPA Pain Management Ladder Initiative) [PDF]

open access: yes, 2018
The main remit of the European Society for Paediatric Anaesthesiology (ESPA) Pain Committee is to improve the quality of pain management in children. The ESPA Pain Management Ladder is a clinical practice advisory based upon expert consensus to help to ...
Adamek   +196 more
core   +1 more source

Pharmacokinetic profiles of the active metamizole metabolites in healthy horses [PDF]

open access: yes, 2016
Metamizole (MT) is an analgesic and antipyretic drug labelled for use in humans, horses, cattle, swine and dogs. MT is rapidly hydrolysed to the active primary metabolite 4-methylaminoantipyrine (MAA).
. LEE, Hk   +7 more
core   +1 more source

Metamizole-associated adverse events: a systematic review and meta-analysis.

open access: yesPLoS ONE, 2015
BackgroundMetamizole is used to treat pain in many parts of the world. Information on the safety profile of metamizole is scarce; no conclusive summary of the literature exists.ObjectiveTo determine whether metamizole is clinically safe compared to ...
Thomas Kötter   +7 more
doaj   +1 more source

Metamizole as a Rare Cause of Drug-Induced Liver Injury

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2022
Drug-induced liver injury (DILI) is a heterogenous entity with a wide range of pathogenetic mechanisms and clinical manifestations. DILI is a diagnosis of exclusion.
Nevena Preveden   +3 more
doaj   +1 more source

Factoring Emerging Markets Into the Relationship Between Global Liquidity and Commodities [PDF]

open access: yes, 2015
Purpose – What caused the mid-2000s world commodity price “bubble” and the recent commodity price growth? Some have suggested that rapid global industrial growth over the past decade is the key driver of price growth.
Chowdhury, Abdur, Landgraf, Steven
core   +2 more sources

Metamizol [PDF]

open access: yespharma-kritik, 2009
Metamizol, ein seit fast 90 Jahren verfügbares Pyrazolon-Schmerzmittel, ist in seinen positiven und negativen Eigenschaften weit weniger gut dokumentiert als moderne Medikamente. In Anbetracht des ungenügend definierten Nutzen/Risiko-Verhältnisses sollte es so zurückhaltend wie möglich verschrieben werden. Als «Allround»-Schmerzmittel ist es zweifellos
openaire   +1 more source

NSAIDs: can the presence of infectious agent influence the choice of analgesic drug? [PDF]

open access: yes, 2017
Purpose. Considering the significant prevalence of comorbid pathology there is a high probability of NSAID use in patients with concomitant infection.
Khomiak, O.V.   +2 more
core   +4 more sources

Metamizole Utilization and Expenditure During 6-Year Period: Serbia vs. Croatia

open access: yesFrontiers in Public Health, 2018
Background: Metamizole is a medication with analgesic, antipyretic, spasmolytic, and weak anti-inflammatory effects. The aim of our study was to evaluate a six-year trend in the utilization and expenditure of metamizole in comparison to other group of ...
Milijana Miljkovic   +6 more
doaj   +1 more source

Retrospective review of anesthetic and analgesic regimens used in animal research proposals [PDF]

open access: yes, 2019
Pain has a profound effect on an animal’s wellbeing. In Germany, researchers using animals have been legally required to reduce any possible pain, suffering, distress or lasting harm to an absolute minimum since 1972.
Flecknell, Paul, Herrmann, Kathrin
core   +2 more sources

Deficits in pain medication in older adults with chronic pain receiving home care: A cross-sectional study in Germany [PDF]

open access: yes, 2020
OBJECTIVE: To analyze the pattern and appropriateness of pain medications in older adults receiving home care. METHODS: We performed a prospective cross-sectional study in patients ≥65 years old having chronic pain and receiving home care in Berlin ...
Algharably, Engi   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy